385 related articles for article (PubMed ID: 33816503)
1. A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
Zheng Y; Tian H; Zhou Z; Xiao C; Liu H; Liu Y; Wang L; Fan T; Zheng B; Tan F; Xue Q; Gao G; Li C; He J
Front Cell Dev Biol; 2021; 9():651406. PubMed ID: 33816503
[TBL] [Abstract][Full Text] [Related]
2. Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.
Li Z; Ma Z; Xue H; Shen R; Qin K; Zhang Y; Zheng X; Zhang G
Front Genet; 2022; 13():917150. PubMed ID: 35873497
[No Abstract] [Full Text] [Related]
3. A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma.
Wang Y; Xie C; Su Y
J Thorac Dis; 2023 Mar; 15(3):1335-1352. PubMed ID: 37065587
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
Wang N; Zhu L; Xu X; Yu C; Huang X
Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
[TBL] [Abstract][Full Text] [Related]
5. A signature-based classification of lung adenocarcinoma that stratifies tumor immunity.
Zhang X; Jiang D; Li S; Zhang X; Zheng W; Cheng B
Front Oncol; 2022; 12():1023833. PubMed ID: 36713530
[TBL] [Abstract][Full Text] [Related]
6. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
[TBL] [Abstract][Full Text] [Related]
7. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma.
Zou X; He R; Zhang Z; Yan Y
Front Genet; 2022; 13():818403. PubMed ID: 35571020
[TBL] [Abstract][Full Text] [Related]
9. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
10. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
Fan T; Zhu M; Wang L; Liu Y; Tian H; Zheng Y; Tan F; Sun N; Li C; He J
Aging (Albany NY); 2020 Dec; 13(2):2397-2417. PubMed ID: 33318300
[TBL] [Abstract][Full Text] [Related]
11. A new prognostic model for
Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C
J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
13. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
14. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
Li Z; Wang W; Wu J; Ye X
Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
16. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
17. An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma.
Han T; Liu Y; Wu J; Bai Y; Zhou J; Hu C; Zhang W; Guo J; Wang Q; Hu D
Sci Rep; 2023 Mar; 13(1):5153. PubMed ID: 36991102
[TBL] [Abstract][Full Text] [Related]
18. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
[TBL] [Abstract][Full Text] [Related]
19. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
[TBL] [Abstract][Full Text] [Related]
20. Identification of CNKSR1 as a biomarker for "cold" tumor microenvironment in lung adenocarcinoma: An integrative analysis based on a novel workflow.
Cai Q; Peng M
Heliyon; 2024 Apr; 10(8):e29126. PubMed ID: 38628722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
